A Phase 2 Study to Conduct Preliminary Evaluations of Safety, Pharmacodynamics and Efficacy by Intravenous Administration of MR11A8 in the Treatment of Patients with Moderate to Severe Acute Respiratory Distress Syndrome (MR11A8-1).

Trial Profile

A Phase 2 Study to Conduct Preliminary Evaluations of Safety, Pharmacodynamics and Efficacy by Intravenous Administration of MR11A8 in the Treatment of Patients with Moderate to Severe Acute Respiratory Distress Syndrome (MR11A8-1).

Completed
Phase of Trial: Phase II

Latest Information Update: 24 May 2016

At a glance

  • Drugs Interferon beta-1a (Primary)
  • Indications Adult respiratory distress syndrome
  • Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
  • Sponsors Maruishi Pharmaceutical
  • Most Recent Events

    • 10 Dec 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top